The yeast mating factor-activated protein kinase pathway is a paradigm for understanding related pathways that transduce diverse signals. New studies of multicellular organisms, however, indicate higher levels of integration of these pathways within networks.
It is remarkable how many extracellular stimuli evoke responses within cells by activating highly related protein kinases. Genetic studies of the mating pheromone pathway in the budding yeast Saccharomyces cerevisiae initially uncovered a cascade of phosphorylation-activated protein kinases, including Ste20, Ste11, Ste7, Fus3 and Kss1, that link both small, Ras-like GTPases and heterotrimeric G proteins to transcriptional activation (Fig. 1) . Several other sets of homologous protein kinases were subsequently shown to control the responses of budding yeast to other perturbations, such as starvation and osmotic shock (see [1] ).
An explanation for why these protein kinases do not seem to act across similar pathways emerged with the discovery that each set may be sequestered by scaffolding proteins. For example, the ␤␥ subunits of a heterotrimeric G protein can complex with Ste 11, Ste7 and Fus3 or Kss1 on a Ste5 protein scaffold, somewhat akin to a series of microprocessors integrated into a common motherboard. Although Ste5-like proteins have not yet been discovered in multicellular organisms, there is a rapidly growing list of mammalian homologues of the yeast protein kinases mentioned above. Recent work on these mammalian kinases cascades is beginning to show how they are integrated into intracellular networks.
MAPK activation and inactivation
The mitogenic signalling pathway in mammals that has come in for the closest scrutiny involves the activation of the extracellularly-regulated kinases (ERKs) Erk1 and Erk2, which are homologous to the budding yeast kinases Fus3 and Kss1. These kinases are also known as mitogen-activated protein kinases (MAPKs), but the ERK designation will be used here to refer to the broader family of ERKrelated kinases that are not necessarily controlled by growth factors. Erk1 and Erk2 play crucial roles even in terminally differentiated cells that cannot proliferate (see [1, 2] ).
Erk1 and Erk2 are broad-specificity, proline-directed serine/threonine kinases that phosphorylate many other kinases and proteins in vitro. Some of these substrates, such as Rsk and Elk1, have been isolated as stable complexes with Erk2, and are probably substrates for it in vivo. The activation of Erk 1 and Erk 2, in turn, is accomplished by phosphorylation on tyrosine and threonine residues by one of the Ste7-related kinases Mek1 or Mek2, which are remarkably specific for Erk1 and Erk2. A 12 kDa protein was recently reported markedly to enhance the rate at which Erk2 is activated by Mek1, but this activator has yet to be characterized [3] . Erk1 and Erk2 may be inactivated by their dephosphorylation by narrow-specificity serine, threonine and tyrosine phosphatases, such as CL100 (also known as 3CH134 and MKP-1) and PAC-1, or broad-specificity phosphatases, such as protein-serine/threonine phosphatase 2A and protein tyrosine phosphatase 1B) (see [1, 4] ).
Mek1 is phosphorylated on serine residues and activated by all three members of the Raf family, and is bound to these enzymes in inactive complexes in the cytoplasm [5] . Raf isoforms are recruited to the plasma membrane by their high affinity for the GTP-bound and activated form of Ras. The substitution of GTP for GDP on Ras is promoted by the guanine nucleotide exchange protein Sos, which is coupled by the adaptor protein Grb2 to tyrosinephosphorylated receptors for mitogens, such as the epidermal growth factor (EGF) receptor. This route of MAPK activation is used to regulate such diverse processes as mitogen signalling in mammalian cells, differentiation of the R7 photoreceptor cells in the compound eye of the fruitfly Drosophila melanogaster, and vulval development in the nematode Caenorhabditis elegans (see [1] ).
Ksr1, a new Raf-like protein
Very recently, genetic studies of D. melanogaster and C. elegans have revealed another kinase, called Ksr1 for kinase suppressor of Ras because its loss can compensate for the expression of activated Ras to restore normal signalling [6] [7] [8] . Murine and human forms of Ksr1 have also been identified [6] . Ksr1 shows about 35-41 % sequence identity to the catalytic domain of Raf, and also has some of the other conserved regions found in Raf. Although it lacks the Ras-binding domain found in Raf, Ksr1 has a cysteine-rich zinc finger like that present in Raf and protein kinase C (PKC). In addition, it has a central serine-and threonine-rich region followed by a FXFPXXS/T motif, as in Raf, and a putative class II SH3-binding domain (PXXPXR/K). Yeast two-hybrid analysis has so far failed to detect interactions between Ksr1 and Ras, Raf, Mek1 or Mek2. It seems that this kinase functions upstream of Raf or on a parallel pathway that is partly redundant with the Raf-Mek1 route. The possibility that Ksr1 catalyzes the phosphorylation and activation of Mek2 warrants further examination, because Mek2 has not been detected in cellular extracts in complexes with any of the Raf isoforms. Mek2 is not phosphorylated and activated by RafA in vitro, although it is by Raf1 and RafB [5] .
The Ras-induced translocation of inactive Raf1-Mek1 complexes to the plasma membrane is insufficient for stimulation of the phosphotransferase activity of Raf1, but seems to permit the multi-site phosphorylation and activation of Raf1 by an array of membrane-associated kinases. The ceramide-activated kinase (CAK) produces the most dramatic stimulation of the phosphotransferase activity of Raf1 by phosphorylating it on Thr268 and Thr269 [9] . The Src kinase also activates Raf1 by phosphorylating Tyr340 and Tyr341 [10] . Phorbol esters may lead to the stimulation of Raf1 by the calcium-activated, phospholipid-dependent PKC. Indeed, PKC can phosphorylate Raf1 at Ser497, Ser499 and Ser619, and stimulate the kinase in vitro (see [1] ). Alternatively, PKC might phosphorylate and activate Ksr1, which could in turn phosphorylate Raf1 at activating sites. Furthermore, phorbol esters might directly stimulate Ksr1 by binding to its zinc finger domain and facilitate Raf1 activation by a PKC-independent mechanism.
The atypical PKC isoform zeta (PKC) is another downstream target of Ras (perhaps by direct interaction or by activation of the phosphatidyl inositol 3-kinase) and has recently been shown to induce the activation of Mek1 and Erk1 in transfected COS cells [11] . How this is achieved is unclear, but this effect of PKC might be mediated through Ksr1, Raf1 or yet another kinase.
Crosstalk between MAP and SAP kinase cascades
Mek1 is phosphorylated and activated by several other kinases -at the MAP kinase kinase kinase, or MAPKKK, level of the cascade -besides Raf1 in vitro (see [1] ). These include: the proto-oncogene-encoded 37 kDa kinase Mos from Xenopus laevis oocytes; a Ras-activated kinase also from X. laevis oocyte cytosol, termed REKS; an insulin-activated 56 kDa kinase in rat adipocytes, called Mekk-I; and a murine Ste11-related kinase known as Mekk1, which may also be directly activated by Ras [12] .
Although Mekk1 is activated in response to mitogens such as EGF, it preferentially phosphorylates another Ste7-like kinase called Sek1 (or Mkk4) in a related stress-activated protein kinase (SAPK)-dependent cascade (see [1, 2, 4] ). For example, Mekk 1 and Sek 1 are activated by the tumour necrosis factor-␣ (TNF␣)-stimulated hydrolysis of sphingomyelin and production of ceramide that activates CAK. Sek1 catalyzes the tyrosine phosphorylation and activation of various isoforms (␣, ␤ and ␥) of the SAPK family, which range in size from 45 kDa to 54 kDa and are 43-44 % identical to the catalytic domains of Erk1 and Erk2. These SAPKs are also known as c-Jun N-terminal kinases (JNKs), because they phosphorylate c-Jun at Ser63 and Ser73 to activate it as a transcription factor. Cotransfection of Mekk1 into COS cells with PKC␤, p21-activated kinase-3 (Pak3) or germinal centre kinase (GCK) causes activation of Mekk1 ( [13] and S.L.P. and Y.L. Siow, unpublished data). Mekk1 does not seem to be directly phosphorylated by any of these kinases, however, so one or more intermediary kinases are postulated.
The mammalian Pak 1, Pak2 and Pak3 isoforms are homologues of Ste20 that are activated upon the interaction of their amino-terminal regulatory domains with the Rho family GTPases Rac and Cdc42 (see [1, 2, 4] ). By contrast, GCK and another mammalian homologue called upstream kinase-1 (UK1) have structures that resemble the S. cerevisiae protein kinase Sps1, which is required for yeast sporulation [1, 13] . These kinases have a Ste20-like catalytic domain in the amino-terminal portion of the kinase and a carboxy-terminal regulatory domain. The stimuli that lead to activation of GCK and UK1 are unknown. Whereas GCK seems specifically to elicit activation of the Mekk1-Sek1-SAPK pathway, the kinase pathway affected by UK1 is still obscure. It is important to note that SAPKs must also be targets for other MAPKKs, because ultraviolet (UV) irradiation of cells strongly activates SAPK and causes c-Jun phosphorylation without stimulating Sek1.
The Pak isoforms also activate another MAPK called Hog (also termed p38 and RK), which phosphorylates and stimulates the phosphotransferase activity of MAPK-activated protein kinase 2 (MAPKAPK2) and the transcriptional activity of ATF2 (see [1, 2, 4] ). MAPKAPK2 was originally described as a kinase that was phosphorylated and activated by Erk2, and this kinase may be responsible for the phosphorylation of the heat shock protein Hsp27 in response to various cellular stresses. Sek1, Mkk3 and Mkk6 are all related MAPKKs that activate Hog in vitro [14] . All three of these kinases are expressed at high levels in human skeletal muscle. Therefore, it seems likely that additional MAPKK activators of Hog and SAPK exist in view of the ubiquitous expression of these MAP kinases. The intermediary kinases that permit Pak to activate Hog are obscure, but they are likely to include a Mekk1-related enzyme.
Although the various MAPK-dependent pathways have been viewed as distinct, it is evident that many stimuli (such as lipopolysaccharide or TNF␣) can turn on all three pathways simultaneously. In some circumstances, activation of the SAP kinases and Hog can selectively induce apoptosis, whereas Erk1 and Erk2 promote cell survival and proliferation [15, 16] . There seem to be extensive interactions between the pathways. For example, the expression of the MAPK phosphatase CL100 is up-regulated in response to Mekk1 induction and specific extracellular stress stimuli such as UV light and the protein synthesis inhibitor anisomycin [17] . This is predicted to cause inactivation of the Raf1-Mek1-Erk2 pathway.
New MAPK pathways
Transforming growth factor-␤ (TGF␤), activins and bone morphogenetic proteins (BMPs) convey signals for the growth and differentiation of cells during embryogenesis, and mediate wound repair and influence immune and endocrine functions in mature organisms. The receptors for these factors are transmembrane proteins containing catalytic domains of protein serine kinases. Until recently, the early post-receptor signalling steps were elusive. However, a 64 kDa protein called TGF␤-activated kinase (TAK1) has been shown to become activated in TGF␤-and BMP4-treated murine osteoblast [18] . TAK1 is about 30 % identical to the catalytic domains of Mekk1 and Raf1, but unlike these kinases, the catalytic domain of TAK1 is located within the amino-terminal half of the enzyme. Although TAK1 phosphorylates and activates Sek1 (but not Mek1) in vitro, it seems likely that TAK1 activates yet another novel MAPK-dependent pathway.
Another 90 kDa MAPK called Erk5 is activated by the 49 kDa MAPKK Mek5 [19] . Both of these kinases are predominantly expressed in human heart and skeletal muscle. The amino-terminus of Mek5 might contain a binding domain for a GTPase related to Rac. Thus, it seems that GTPases may interact with kinases on many tiers of MAPK-dependent pathways. There are many more MAPKs (such as Erk3, Erk4, Kkailre and Mpk) that are regulated by unknown stimuli through undefined pathways that probably include Ste7-, Ste11-and Ste20-like components. The complete sequence of the human genome should uncover all of the human protein kinases; however, it will remain a daunting task to establish the physiologically relevant connections among these enzymes.
